Albion VC

Albion typically invests £2-5m for a minority stake Series A and early Series B. They support outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market. They look at most sectors, with a particular focus on digital B2B companies – enterprise software and technology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive. They also invest in companies commercialising IP from University College London via the UCL Technology Fund.

Jessica Bartos

Investment Manager, AlbionVC

David Gudgin

Partner

Andrew Michael Impey

Partner

Henry Stanford

Partner

Macro Yu

Investment Director

36 past transactions

Abcodia

Venture Round in 2014
Abcodia Ltd. engages in the discovery and validation of molecular biomarkers for disease diagnosis and screening. It offers Roca Test solutions for early ovarian cancer detection to customers in Arizona, Illinois, Massachusetts, New Jersey, Texas, Georgia, Michigan, Missouri, North Carolina, Nevada, Ohio, Oregon, Virginia, Washington, Wisconsin, the District of Columbia, and the United Kingdom. The company was incorporated in 2010 and is based in London, United Kingdom.

Mirada Medical

Venture Round in 2014
Mirada Medical is a prominent global brand in medical imaging software. Mirada’s innovative software solutions are routinely used in radiology, molecular imaging, radiation oncology and in multidisciplinary meetings throughout hospitals, imaging centers and cancer centers worldwide. Mirada excels at combining scientifically advanced technology with practical application for diagnosis, management and treatment of cancer and other diseases. - See more at: http://www.mirada-medical.com/about-mirada-medical/#sthash.Sp4rzAG0.dpuf

Celoxica

Venture Round in 2011
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Xceleron Inc.

Series B in 2006
Xceleron believes that AMS technology and our expertise can get life-changing products quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.

Innovation Broking

Venture Round in 2015
Innovation Broking is an independent commercial insurance broker. It provide corporate insurance broking services for companies and organisations seeking a knowledgeable and expert board level partnership.

Orchard Portman House Hospital

Acquisition in 2010
Orchard Portman House Hospital is a mental health hospital and provides care and rehabilitative support of people.

Helveta

Funding Round in 2009
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

Green Highland Renewables

Venture Round in 2014
Green Highland Renewables (GHR) specialises in developing small scale run of river hydro projects from about 50kW to 2MW. GHR provides advice and solutions to landowners and communities through the whole process of design, procurement and operation and helps provide them with a sustainable future whilst supporting Scotland’s responsible commitment to climate change.

Symetrica

Venture Round in 2019
Symetrica Ltd. provides integrated radiation detection and identification technologies for custom organizations and government departments worldwide. Its technology for homeland security include gamma-ray detection and identification sub-systems; helium-3 neutron detector technology; and spectroscopic PVT detector systems. The company serves the military and homeland security markets. Symetrica Ltd. was founded in 2002 and is based in Southampton, United Kingdom with additional office in Maynard, Massachusetts.

Helveta

Venture Round in 2008
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.

MyMeds&Me

Venture Round in 2013
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry. The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.

Locum's Nest

Venture Round in 2018
Locum’s Nest is an innovative employment platform revolutionising the way locum staff are recruited in the NHS. At a time where NHS funding is stretched to the limit, we aim to decrease the need of external agencies and bring the costs right down to reduce avoidable spending. Locum’s Nest will allow staff to fully customise, filter and automate their search for locum posts. Gone are the days of poor job matching, constant phone calls and repeated employment checks.

Grapeshot

Series C in 2016
Grapeshot Limited develops software products for marketers and advertising agencies. It offers Contextual Intelligence Platform that empowers businesses with real-time targeting, data enrichment, and audience discovery. The company provides custom targeting, predictive targeting, brand safety, GDPR compliance, campaign analytics, brand stories, reporting and analytics, and audience segmentation solutions. It serves brands, DSPs, media agencies, platforms, publishers, and trading desks. The company was founded in 2002 and is based in Cambridge, United Kingdom. It has additional offices in London, New York, Chicago, Los Angeles, Singapore, Cambridge, Palo Alto, Toronto, Hong Kong, Shanghai, and Sydney. As of May 15, 2018, Grapeshot Limited operates as a subsidiary of Oracle Corporation.

G.Network

Venture Round in 2017
G.Network is the next generation communications service provider exclusively focused on Central London. The company provides affordable ultra-fast (up to 10Gbps) fibre connectivity to businesses. We are building our own ‘Fibre to the Premises’ (FTTP) fibre optic network directly into premises across the Capital meaning we can offer unrivalled quality and speeds at affordable prices. Bridging the gap between constrained copper-based connectivity and expensive, long lead time leased lines, G.Network ‘s fibre–based connectivity will transform the way you do business.

Blackbay

Venture Round in 2006
Blackbay Ltd designs and develops mobility enabled solutions for the transport and logistics industry. The company offers Delivery Connect, a cloud-based freight movement management solution; No Trucking Worries, a cloud-based solution for drivers and dispatchers; and Expect, a cloud-hosted solution that provides the tools to manage and communicate with consumers throughout the delivery and collection process. It partners with ALK Technologies, Accenture, Peak Ryzex, Honeywell, and NetDespatch. Blackbay Ltd. was formerly known as iTouch Business Mobility. The company was founded in 2004 and is based in Derby, United Kingdom. Blackbay Ltd is a former subsidiary of iTouch plc. As of April 4, 2017, Blackbay Ltd operates as a subsidiary of BluJay Solutions Ltd.

MPP Global

Series B in 2017
MPP Global Solutions Ltd., trading as MPP Global, develops and provides integrated cloud identity management, customer relationship management (CRM), and ecommerce solutions through its eSuite platform. Additionally, it offers metering, marketing, promotion, billing, payment, subscription, reporting, and analytics solutions. The company caters to television, media, publishing, and entertainment industries. Its clientele include Sky, The Times, L''Equipe, The Daily Mail, el Mundo, el Tiempo, Local Media Group, The Irish Times, TP Vision, and Universal Music Group. MPP Global Solutions Ltd. was founded in 2000 and is headquartered in Warrington, United Kingdom with additional offices in Europe, United States, South America, and Australia.

Red-M Group

Venture Round in 2005
Red-M Group Limited provides wireless networking solutions. It provides last mile and building to building radio based Ethernet connectivity solutions, including the delivery of wireless systems in the corporate head quarters, airports, shopping centers, stadiums, railway stations, and hospitals. The company serves health care, cellular, regulator, enterprise, transport, public sector, retail, and finance industries. Red-M Group Limited was formerly known as Red-M (Communications) Limited. The company was founded in 1999 and is based in Horsham, the United Kingdom.

Rostima

Venture Round in 2008
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Active Lives Care

Venture Round in 2014
Active Lives Care was incorporated in 2013 and is based in London, United Kingdom.

Oviva

Series A in 2017
Oviva provides technology-enabled dietetic services and their goal is to help people lead happier & healthier lives. They have developed unique, personalised behaviour change programmes that combine our smartphone app and learning portal to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions.

Grapeshot

Venture Round in 2014
Grapeshot Limited develops software products for marketers and advertising agencies. It offers Contextual Intelligence Platform that empowers businesses with real-time targeting, data enrichment, and audience discovery. The company provides custom targeting, predictive targeting, brand safety, GDPR compliance, campaign analytics, brand stories, reporting and analytics, and audience segmentation solutions. It serves brands, DSPs, media agencies, platforms, publishers, and trading desks. The company was founded in 2002 and is based in Cambridge, United Kingdom. It has additional offices in London, New York, Chicago, Los Angeles, Singapore, Cambridge, Palo Alto, Toronto, Hong Kong, Shanghai, and Sydney. As of May 15, 2018, Grapeshot Limited operates as a subsidiary of Oracle Corporation.

Proveca

Venture Round in 2014
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

Proveca

Venture Round in 2013
Proveca Ltd., a pharmaceutical company, identifies, researches, and licenses off-patent medicines with a focus on the pediatric market. The company’s product portfolio focuses on neurology, cardiology, immunology, analgesia, and pain management. It develops medicines for the treatment of sialorrhoea (chronic pathological drooling) and epilepsy; heart failure, haemodynamic insufficiency, and transplant rejection; and acute pain as well as for children with chronic illnesses. The company was founded in 2010 and is based in Daresbury, United Kingdom.

Perpetuum

Series C in 2014
Perpetuum Ltd. engineers, manufactures, and commercializes electromagnetic vibration harvesting micro generators. It offers battery-free vibration energy harvesters and wireless sensor nodes for passenger and freight applications; and industrial vibration energy harvesters and industrial wireless sensor nodes that are used for process monitoring and equipment condition-based monitoring in industrial environments. The company also provides wireless transmitters and programmable measurement nodes. It serves rail, oil and gas, chemicals, power generation, water and wastewater treatment, and process manufacturing industries. Perpetuum Ltd. was incorporated in 2004 and is based in Southampton, United Kingdom.

Erin Solar

Venture Round in 2013
Erin Solar is a commercial solar panel management company. Erin Solar provide commercial landlords with solar photovoltaic solutions in Northern Ireland.

Mi-Pay

Post in 2014
Mi-Pay delivers outsourced payment solutions to digital e-commerce clients, primarily in the mobile sector. Its clientele is comprised of mobile operators, virtual operators, prepaid card providers, financial institutions, and media companies. The company also provides a portfolio of client branded, mobile payment services for mobile operators, financial service providers, utility companies, and media owners from their offices in the U.K., Romania, U.A.E., and India. Its infrastructure allows end customers to top-up using multiple payment methods such as credit or debit card, PaypalTM, bank transfer, and direct debit across all channels. Mi-Pay was founded in 2003.

DYSIS Medical

Venture Round in 2014
DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.

Haemostatix

Venture Round in 2012
Haemostatix Ltd. develops a peptide-based platform technology to develop a pipeline of products to treat surgical bleeding with further applications in tissue repair and regenerative medicine. Its pipeline includes PeproStat, a coagulant/haemostat that is applied directly to a wound during surgery to control bleeding. The company was founded in 2003 and is based in Nottingham, United Kingdom. As of May 24, 2016, Haemostatix Ltd. operates as a subsidiary of Ergomed plc.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Hazy

Seed Round in 2018
Hazy Limited develops an application that provides automatic data anonymisation using artificial intelligence. The company develops a workflow tool that allows users to share data automatically and adapt to changing datasets. Hazy Limited was formerly known as Anon AI Limited. Hazy Limited was incorporated in 2017 and is based in London, United Kingdom.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Quantexa

Series B in 2018
Quantexa is an information technology company that specializes in the fields of analytics, data science, and big data. Quantexa enables companies and institutions to make better decisions from their data. Quantexa’s technology uses real-time entity resolution with network analytics and AI to knit together vast and disparate data sets and drive actionable intelligence. Led by a team of experts in advanced analytics and data-focused solutions, Quantexa is operating globally with offices in the UK, Brussels, New York, Boston, and Sydney.

Rostima

Venture Round in 2014
Rostima is a global leader in the development and implementation of intelligent Enterprise Workforce Planning and Management Software Systems for complex workforce environments. The open and flexible technologies developed by Rostima enable organisations to optimise their labour schedules by matching workload to staff resources thereby increasing operational efficiency, reducing labour costs, improving service levels and staff retention. Headquartered in the UK, Rostima has an office and R&D centre in Kuala Lumpur. Currently, over 30,000 personnel are managed by the Rostima product with a loyal customer base spread across Europe, Middle East, USA and Asia Pacific.

Silent Herdsman

Venture Round in 2014
Silent Herdsman’s vision is to be the leading global provider of predictive analytics software for dairy and beef farmers, that improves herd performance, business efficiency and animal welfare. Crucially, the collar triggers an alert to farmers when cows are on heat, providing farmers with advanced knowledge to activate insemination at critical times. This in turn enables them to produce more milk from the impregnated cows and increase their yields from each herd. The Silent Herdsman® triggers its alert via wireless technology to any mobile device such as a farmer’s mobile phone, tablet or laptop. Uniquely, its wireless technology can travel over long distances meaning it is suitable for farms hosting 100 to 20,000 cows. Its unique differentiator includes monitoring herds across large geographical distances on farms hosting several thousand beef or dairy cows.

Radnor House School

Venture Round in 2010
Radnor House School (Holdings) Limited operates a co-educational school for children. The company also focuses on students with special education needs and disabilities (SEND) through its SEND program. Radnor House School (Holdings) Limited was incorporated in 2010 and is based in Twickenham, United Kingdom.

DYSIS Medical

Venture Round in 2014
DYSIS Medical is a medical device company that designs, develops, manufactures and markets imaging systems focusing on the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DYSIS Medical has developed a proprietary technology that has the potential to address a number of diseases affecting millions of people worldwide and costing billions of dollars to healthcare systems.